Glenn S. Hirsch, MD

Crenezumab Does Not Reduce Clinical Decline in Adults With Early Alzheimer Disease

Advancing the Treatment Paradigm for Myasthenia Gravis and Looking Toward the Future

Institutional Perspectives in Neurology, Chaired by Riley Bove, MD

Majority of Canadian Physicians Treat Primary Headache Disorders With Nonsteroidal Anti-inflammatory Drugs, Dopamine Receptor Antagonists